Cardinal Capital Management holds a diversified book of 138 stocks worth $826.3M as of Q2 2026 (disclosed Jul 21, 2026, a ~45-day 13F lag). This quarter they opened Cal-Maine Foods Inc and trimmed Eli Lilly & Co. Their largest long position is Eli Lilly & Co at 4% of the equity book. Cloning the disclosed picks since 2024 would be +29% (+15.6%/yr). That is a simulation of the disclosed long book, not audited returns.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1434845/holdings"
Use Arkolith to show Cardinal Capital Management's latest holdings, largest changes, and filing provenance.
Following at the filing date actually beat the quarter-end book by 3.6 points over this window.
Growth of $10,000 cloning Cardinal Capital Management's disclosed long 13F book, rebalanced on each filing date (so it reflects the ~45-day reporting lag, no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: diversified book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
99% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co COM | $31.8M | 26.5K | 3.8% | ▼−1.1% Reduced · −287 sh | |
| 2 | Johnson & Johnson COM | $29.2M | 114.8K | 3.5% | ▼−1.3% Reduced · −2K sh | |
| 3 | Apple Inc COM | $25.0M | 86.4K | 3.0% | ▼−0.7% Reduced · −580 sh | |
| 4 | Alphabet Inc CAP STK CL A | $22.7M | 63.6K | 2.7% | ▼−1.0% Reduced · −665 sh | |
| 5 | Bank Of NY Mellon Corp COM | $19.6M | 135.4K | 2.4% | ▼−1.1% Reduced · −1K sh | |
| 6 | Costco Wholesale Corporation COM | $19.3M | 20.6K | 2.3% | ▼−0.6% Reduced · −131 sh | |
| 7 | JPMorgan Chase & Co COM | $19.1M | 58.4K | 2.3% | ▼−0.6% Reduced · −366 sh | |
| 8 | Microsoft Corp COM | $18.7M | 50.1K | 2.3% | ▲+1.1% Added · +564 sh | |
| 9 | Cisco Sys Inc COM | $18.3M | 156.1K | 2.2% | ▼−1.0% Reduced · −2K sh | |
| 10 | Deere & Co COM | $17.5M | 27.6K | 2.1% | ▼−1.0% Reduced · −286 sh | |
| 11 | Walmart Inc COM | $17.4M | 153.9K | 2.1% | ▼−0.7% Reduced · −1K sh | |
| 12 | Exxon Mobil Corp COM | $15.7M | 115.0K | 1.9% | ▼−0.3% Reduced · −377 sh | |
| 13 | Cummins Inc COM | $14.9M | 20.9K | 1.8% | ▼−0.8% Reduced · −164 sh | |
| 14 | Qualcomm Inc COM | $12.9M | 69.6K | 1.6% | ▼~0% Reduced · −18 sh | |
| 15 | Emerson Elec Co COM | $12.7M | 88.4K | 1.5% | ▼−0.5% Reduced · −412 sh | |
| 16 | International Business Machs COM | $12.6M | 44.7K | 1.5% | ▼~0% Reduced · −4 sh | |
| 17 | Merck & Co Inc COM | $12.4M | 96.2K | 1.5% | ▼−0.4% Reduced · −402 sh | |
| 18 | Ecolab Inc COM | $12.0M | 43.0K | 1.5% | ▼−0.3% Reduced · −136 sh | |
| 19 | Illinois Tool WKS Inc COM | $11.8M | 43.4K | 1.4% | ▼−0.4% Reduced · −180 sh | |
| 20 | Keysight Technologies Inc COM | $11.6M | 33.0K | 1.4% | ▼−16% Reduced · −6K sh | |
| 21 | Labcorp Holdings Inc COM SHS | $10.8M | 38.5K | 1.3% | ▼−0.3% Reduced · −103 sh | |
| 22 | Lowes Cos Inc COM | $10.6M | 48.2K | 1.3% | ▼−0.1% Reduced · −36 sh | |
| 23 | Truist Finl Corp COM | $10.3M | 207.7K | 1.3% | ▼−0.5% Reduced · −944 sh | |
| 24 | Automatic Data Processing In COM | $10.1M | 44.7K | 1.2% | ▲+0.9% Added · +385 sh | |
| 25 | Agilent Technologies Inc COM | $10.0M | 75.2K | 1.2% | ▼−0.1% Reduced · −110 sh | |
| 26 | ConocoPhillips COM | $9.6M | 92.0K | 1.2% | ▲+0.1% Added · +121 sh | |
| 27 | Starbucks Corp COM | $9.5M | 93.3K | 1.2% | ▼−0.2% Reduced · −222 sh | |
| 28 | State STR Corp COM | $9.3M | 54.9K | 1.1% | ▼−0.8% Reduced · −456 sh | |
| 29 | Oil Dri Corp Amer COM | $8.9M | 87.4K | 1.1% | ▼−0.8% Reduced · −685 sh | |
| 30 | Argan Inc COM | $8.8M | 11.0K | 1.1% | ▼−37% Reduced · −6K sh | |
| 31 | 3M Co COM | $8.8M | 54.3K | 1.1% | ▼−0.6% Reduced · −342 sh | |
| 32 | Procter & Gamble Co COM | $8.8M | 59.8K | 1.1% | ▲+0.9% Added · +527 sh | |
| 33 | Price T Rowe Group Inc COM | $8.3M | 73.0K | 1.0% | ▲+0.1% Added · +57 sh | |
| 34 | Hasbro Inc COM | $8.2M | 99.8K | 1.0% | ▼−0.2% Reduced · −249 sh | |
| 35 | Royal BK Cda COM | $8.2M | 39.6K | 1.0% | ▼−0.4% Reduced · −152 sh | |
| 36 | F5 Inc COM | $8.1M | 19.4K | 1.0% | ▲+0.2% Added · +40 sh | |
| 37 | National Fuel Gas Co COM | $7.8M | 100.7K | 0.9% | ▼−0.6% Reduced · −624 sh | |
| 38 | Novartis AG SPONSORED ADR | $7.8M | 49.7K | 0.9% | ▼~0% Reduced · −14 sh | |
| 39 | Curtiss Wright Corp COM | $7.8M | 10.2K | 0.9% | ▼−0.5% Reduced · −55 sh | |
| 40 | Idexx Labs Inc COM | $7.4M | 14.2K | 0.9% | ▲+0.3% Added · +44 sh | |
| 41 | Coca Cola Co COM | $6.8M | 83.6K | 0.8% | ▼−0.7% Reduced · −608 sh | |
| 42 | Medtronic PLC SHS | $6.7M | 85.0K | 0.8% | ▲+1.6% Added · +1K sh | |
| 43 | United Therapeutics Corp Del COM | $6.5M | 12.0K | 0.8% | ▼−1.3% Reduced · −163 sh | |
| 44 | Synaptics Inc COM | $6.2M | 49.7K | 0.7% | ▲+0.3% Added · +161 sh | |
| 45 | Bristol-Myers Squibb Co COM | $6.1M | 105.1K | 0.7% | ▲+0.5% Added · +568 sh | |
| 46 | McCormick & Co Inc COM NON VTG | $5.8M | 114.4K | 0.7% | ▲+7.1% Added · +8K sh | |
| 47 | Fedex Corp COM | $5.7M | 18.3K | 0.7% | ▲+0.3% Added · +61 sh | |
| 48 | Toronto Dominion BK Ont COM NEW | $5.6M | 46.3K | 0.7% | ▼−0.1% Reduced · −53 sh | |
| 49 | Bank Nova Scotia B C COM | $5.4M | 62.6K | 0.7% | ▲+0.7% Added · +441 sh | |
| 50 | Regeneron Pharmaceuticals COM | $5.2M | 8.4K | 0.6% | ▼−0.5% Reduced · −39 sh |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Jul 21, 2026 | 138 | $826.3M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | Apr 8, 2026 | 136 | $775.6M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Jan 30, 2026 | 133 | $755.0M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Oct 23, 2025 | 131 | $723.4M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Jul 15, 2025 | 128 | $681.4M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | Apr 18, 2025 | 132 | $645.7M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Jan 31, 2025 | 131 | $637.7M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Oct 16, 2024 | 130 | $642.8M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.